Abstract
The Burrill Biotechnology Report has the detailed market intelligence you need
each month to obtain an accurate overview of all the latest global
developments and trends. Our July launch issue will provide the 2008 half-year
biotech report. This essential update of Biotech 2008 covers all the latest
news, products, medicines, scientific advances, financials and venture
funding. Your subscription will also entitle you to a wide range of special
reports and results on key surveys that we will be conducting
monthly.
Burrill is the creator, sponsor and facilitator of over a dozen leading
industry conferences worldwide and publishes a wide range of bio-intelligence
reports including: its annual State of the Industry, The Personalized Medicine
Report, The Stem Cell Report, and periodic newsletters covering Canada, China,
Europe, India, Japan and Partnering/M&A.
Table of Contents
Publisher' s Letter
Editor' s Letter
Feature : CEO Inter view
Therapeutic Focus
Industry Metrics
- Personalized Medicine
- Agbio
- Wellness
- Industrial Biotech
- Diagnostics
Changewave Genetic Testing Survey
Half Year 2008 Report on the Industry
- M&A and Partnering
- Finance & Capital Markets
By the Numbers : H1 2008
- Total Financings
- Historical US Biotech Industry Financings
- Public Financings by Company
- Public Financings by Therapeutic Area
- Top 20 Venture Financings
- Venture Financings by Therapeutic Area
- Venture Financings by State
- Change in Biotech Market Cap
- Burrill Public Biotech Companies Performance
- Biotech IPOs Performance
International
- Canada
- Europe
- China
- India
Industry Financial Data H1 2008
| 
